Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison study of quality of life in advanced lung cancer patients on tyrosine kinase inhibitor and platinum doublet chemotherapy.

Indian journal of cancer - 1 Jan 2000

Udupa K, Rajendranath R, Sagar T G

Abstract excerpt

INTRODUCTION: Lung cancer is most common cause of cancer death in the world. Most of the patient are diagnosed in the late stages and receive only palliative treatment. The main objective of the palliative chemotherapy is to improve survival as well as the quality of life (QOL). QOL is the most neglected dimension of cancer care in developing countries like India. Palliative chemotherapeutic agent which has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carboplatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Protein-Tyrosine Kinases

Share to Quality of Life

Source

Identifiers

PMID: 29199681
DOI: 10.4103/0019-509X.219558

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Comparison study of quality of life in advanced lung cancer patients on tyrosine kinase inhibitor and platinum doublet chemotherapy.PMID 29199681Read ↗

Study of gefitinib maintenance in unselected patients with metastatic primary lung adenocarcinoma: A descriptive study.Semantic proximity Read ↗

Complementary and Alternative Medicine and Quality of Life in Turkish Lung Cancer Chemotherapy Patients Safiye OZKAN SARILI¹ (Sorumlu Yazar), Fırat DEMIR²Semantic proximity Read ↗

Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC.Semantic proximity Read ↗

Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: A real-world multicentric cohort analysis from India.Semantic proximity Read ↗

Lower lymphocyte percentage and higher platelet count as poor prognostic factors for patients with epidermal growth factor receptor–mutated lung adenocarcinoma receiving tyrosine kinase inhibitors as first-line treatmentSemantic proximity Read ↗

Clinical profile and outcomes of patients with Stage IV adenocarcinoma of lung: A tertiary cancer center experience.Semantic proximity Read ↗

Evolving trends in lung cancer: Epidemiology, diagnosis, and management.Semantic proximity Read ↗

Concurrent radiotherapy and chemotherapy with erlotinib followed by maintenance erlotinib in patients with Epidermal Growth Factor Receptor mutation- positive adenocarcinoma lung.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.